Reckitt Sues To Block Par's Generic Suboxone
Reckitt Benckiser Pharmaceuticals Inc. sued Par Pharmaceutical Cos. Inc. on Tuesday in Delaware federal court, claiming the generic-drug maker is infringing two of its patents for the opiate addiction treatment Suboxone....To view the full article, register now.
Already a subscriber? Click here to view full article